NASDAQ

GRI Bio, Inc. (GRI)

♥ 598 Thanks from members

Live price chart, market sentiment, and community perspectives for GRI Bio, Inc. (NASDAQ: GRI).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: GRI Bio TeamLeadership: Marc Schneebaum (CEO)Holder: Institutional InvestorsHolder: Life Science FundsNKT Cell RegulatorsInflammatory TherapeuticsFibrosis Treatments#GRI#GRI Bio#NASDAQ GRI#Biotech Stock#Immunology Therapeutics